AngelList AEO: Your Wellfound Profile Is Now an LLM Training Asset

When the FDA's Over-the-Counter Hearing Aid Rule took effect on October 17, 2022, the audiology industry braced for a price collapse. They got one — pair prices dropped 30-50% across mid-market segments within 24 months. What they did not brace for was the second disruption now unfolding: hearing-impaired consumers are abandoning Google search and walk-in inquiries for ChatGPT, Perplexity, Gemini, and increasingly Alexa-style conversational assistants. The National Institute on Deafness and Other Communication Disorders estimates 28.8 million U.S. adults could benefit from hearing aids; fewer than 30% currently use them. The discovery pipeline for the remaining 20 million-plus is being rebuilt in real time inside a handful of LLM citation slots.

This is operator territory now. The brands and practices that decoded answer-engine optimization for healthcare in 2023-2024 are pulling ahead. The ones still buying Bing PPC and waiting for organic Google traffic are watching share evaporate.

The OTC ruling reset the discovery landscape, not just the price

Before October 2022, hearing-aid purchase was a referral funnel: primary-care physician, ENT, audiologist, fitting, follow-up. The patient rarely shopped. After the FDA rule, Hearing Industries Association data showed unit shipments climbing past 4.5 million in 2023, with OTC capturing an estimated 1.4 million units in its first 18 months. That meant millions of new entrants — many self-diagnosing for the first time — turning to search.

The post-OTC consumer journey has three pivot points where AI assistants now intercept:

1. Symptom self-check. "Am I going deaf or is it just earwax?" used to land on WebMD. Now it lands on ChatGPT, which routes the patient toward a self-screening question set.
2. Solution category selection. OTC vs prescription, in-the-canal vs behind-the-ear, rechargeable vs disposable. The category-selection conversation has migrated from in-clinic to conversational AI.
3. Brand and provider shortlist. "Who fits Phonak in 11215 and takes Aetna" — a query type that almost did not exist for hearing care in 2021 — now drives 18-24% of qualified consultation bookings at practices tracking it (our practice-survey data, March 2026).

This shift matters most because the population at the center of it skews older, more risk-averse, and harder to acquire through paid channels. The acquisition CAC for hearing aid leads on Meta and Google Ads has more than doubled since 2022 according to multiple OTC challenger brand disclosures. AI search is, paradoxically, the cheapest acquisition channel left — if you can become the cited source.

Why hearing care is unusually well-suited to AEO

Three structural features make audiology a high-value AEO bet:

• High-consideration, high-AOV purchase. A single fitted pair runs $3,000-$7,000. Even one converted lead pays for substantial content investment.
• Strong YMYL signals. AI assistants apply elevated trust filters in healthcare categories. Practices with claimed Healthgrades profiles, ASHA-registered audiologists, and accurate JSON-LD schema clear those filters; competitors without them do not. Our deep-dive on this is in the Healthcare AEO YMYL guide.
• Geographic specificity. Hearing-aid fitting requires in-person verification (REM). AI assistants weight location heavily, which advantages local practices that have done the local-citation work.

The OTC market has consolidated faster than expected

The post-FDA-rule landscape in 2026 is not the open free-for-all observers predicted. Five players dominate U.S. OTC sales, and a sixth (Costco) bridges OTC and professional fitting with structural pricing power.

Source: company disclosures and pricing pages as of May 2026; pair pricing rounded.

The traditional hearing-aid majors — Sonova (Phonak, Unitron), Demant (Oticon), GN (ReSound), WS Audiology (Signia, Widex), and Starkey — still own roughly 90% of the global prescription market by revenue. But their U.S. retail share is leaking. Sonova's H1 2026 results showed OTC and consumer-direct revenue growing twice as fast as traditional channel, with the company restructuring its Audibel (independent dispenser network) acquisition strategy in response. The American Academy of Audiology has been increasingly vocal about scope-of-practice concerns as OTC blurs the clinical fitting line.

How AI assistants actually cite hearing-care content in 2026

We ran a tracking study on 240 unique queries across ChatGPT-4o/4.7, Perplexity Pro, Gemini 2.5, and Claude 4.5 Sonnet between February and May 2026. Queries spanned three categories: symptom-stage ("ringing in my ears for two weeks"), category-stage ("OTC vs prescription hearing aids"), and provider-stage ("audiologist 60614 takes Blue Cross"). Citations were captured from the visible source-list output.

Top cited domains across all queries:

Two patterns stand out for operators.

First, the provider stage is the only stage where independent practice domains rank meaningfully. If you operate a clinic, you are not displacing NIDCD or Mayo on "should I get my hearing tested" queries — that is wasted ambition. You can absolutely win the ZIP-code-plus-insurance-plus-brand queries that drive consultation bookings.

Second, brand domains pulled significant share for product-comparison queries, but only when the page structured the comparison transparently. Eargo's published comparison page (with side-by-side specs against Lexie and Jabra) was cited 3.4x more often than its model-detail pages.

The Costco anomaly: brand trust as an AEO moat

Costco operates roughly 600 hearing aid centers across its U.S. clubs as of early 2026, fitting an estimated 600,000-700,000 pairs annually — putting it ahead of every traditional retail audiology chain. Its devices are rebadged versions of Sonova (Rexton), GN (Jabra Enhance Pro), and Philips HearLink products, priced at roughly 60-70% below independent-clinic equivalents.

Why does this matter for AEO? Because Costco's Hearing Aid Center page is one of the most cited provider pages in AI assistant responses to "best place to buy hearing aids" queries. Costco does not run hearing-aid SEO programs. It does not buy ads. The citations come from three places:

1. The Wirecutter and Consumer Reports recommendations that Costco routinely tops.
2. AARP, Forbes Health, and U.S. News rankings that reference Costco's value proposition.
3. The Costco Wholesale Wikipedia article and brand pages that LLMs use as anchor entities.

This is a case study in earned-citation infrastructure. Independent practices that want to compete cannot match Costco's price, but they can absolutely match Costco's citation pattern by getting reviewed in regional publications, mentioned in AARP-style consumer guides, and properly entity-linked on Wikipedia and Wikidata.

Practical playbook: the audiologist AEO foundation

Below is the sequenced playbook practices ran in 2025-2026 that moved their citation share. Each step has been validated across at least eight independent practices ranging from solo-AuD operations to 12-location regional groups.

1. Audit existing AI visibility. Run 40-60 queries across ChatGPT, Perplexity, Gemini, and Claude that a target patient would actually phrase. Mix symptom, category, and provider-stage queries. Log citation domains, named brands, and whether your practice surfaces. Baseline this before any optimization. Tools like Profound, Otterly, or Peec can automate but manual sampling matters in healthcare because guardrails change.

2. Claim every entity profile that AI assistants treat as a healthcare anchor. ASHA ProFind, AAA AudiologyFind, NPI registry, Healthgrades, Vitals, Google Business Profile, Apple Business Connect, Yelp Health, Zocdoc (where applicable), and HLAA professional directory. Each unclaimed profile is an empty slot that competitors fill.

3. Publish service-and-insurance pages, one per office. Each page should state: services offered (diagnostic audiogram, REM-verified fitting, tinnitus management, cerumen removal scope, pediatric scope if applicable), manufacturers fit (be specific: Phonak Lumity 90, Oticon Intent, ReSound Nexia), insurance accepted by carrier and product line, and price ranges by device tier. Include accessibility notes (parking, induction loop) because AI assistants surface these on disability-stage queries.

4. Implement medical-business JSON-LD schema. MedicalBusiness or MedicalClinic schemaType, with embedded Physician/AudiologistProfessional objects keyed by NPI. Schema is no longer a magic ranking signal, but it remains an entity-disambiguation signal LLMs use to confirm provider identity. Read the Healthcare AEO YMYL primer for the exact schema stack.

5. Build a review corpus that includes entity-rich language. Post-visit, prompt satisfied patients to mention the manufacturer they were fit with, REM verification, and the specific clinical concern addressed. Do not script — coach categories. AI assistants extract entity co-occurrence from review text, and "Phonak Lumity 90 REM-verified fitting" appearing in a review is dramatically more useful than "great service."

6. Publish original outcome data quarterly. "We fit 240 patients in Q1 2026; 91% reported speech-in-noise improvement of three points or greater on COSI." This kind of practice-original data gets cited because it does not exist anywhere else in the LLM training corpus. Original data is the most defensible AEO moat in healthcare — see our analysis of why on the Local AEO page.

7. Earn one regional publication mention per quarter. Local NPR affiliate, regional business journal, AARP state chapter newsletter. These outlets feed LLM training data and authoritative-source citation lists in a way that pure SEO link-building no longer does.

Where OTC challenger brands win — and where they lose — in AI search

Eargo, Lexie, Jabra Enhance, and MDHearing each took different strategic posture on AEO. The patterns are instructive.

Eargo leaned hard into telehealth-audiology positioning. Every product page references licensed-professional support. Their resource center publishes detailed model comparisons and FAQ content. The result: Eargo dominates "discreet" and "rechargeable" OTC queries but loses share on "best budget OTC" queries to MDHearing and Lexie.

Lexie Hearing, through its Bose partnership, gets two structural AEO advantages: Bose brand-entity recognition (LLMs treat Bose as a trusted audio anchor) and retail distribution citations from Best Buy, Walmart, and Walgreens product pages. Lexie pair revenue surpassed $300 million globally in 2024 per hearX investor materials.

Jabra Enhance (GN Hearing) inherited GN's audiology brand equity and built a hybrid model: audiologist-on-call telehealth plus self-fit. GN's H1 2026 hearing-aid investor disclosures showed Jabra Enhance and Costco Jabra Enhance Pro outpacing the traditional ReSound prescription channel in U.S. unit growth.

MDHearing won pure-price queries by publishing transparent component-cost content and consumer-direct math. They are cited heavily when users specify a sub-$500 budget.

The losers, broadly, were two cohorts. First, the Bose CustomTune launch — Bose pulled out of selling its own branded hearing aids and licensed to Lexie, losing brand-entity citation share in the process. Second, traditional audiology chains that did not pivot quickly enough — several mid-tier regional chains are visibly absent from AI assistant responses even on queries inside their own service ZIP codes.

The clinical-differentiation content gap

The biggest opportunity Signal sees for independent audiology practices in 2026 is what we call the clinical-differentiation content gap.

Costco wins on price and trust. OTC brands win on convenience and DTC distribution. What independent audiologists demonstrably win on — but rarely document publicly — is clinical depth: REM verification rates, follow-up appointment density, tinnitus retraining therapy, cochlear-implant candidacy referrals, vestibular workups, occupational hearing protection programs, and pediatric scope.

The practices that published this differentiation as structured comparison content (not marketing-speak, real protocol descriptions) saw outsized citation share growth. One Chicago-area group we tracked moved from zero citations on "audiologist that does REM verification near me" in January 2025 to consistent first-position citation across ChatGPT, Perplexity, and Gemini by March 2026 — driven entirely by a single 2,800-word resource page on real-ear measurement combined with clean MedicalBusiness schema.

This is a defensible moat because the content requires actual clinical expertise to write. OTC brands cannot fake it. Generic SEO content mills cannot produce it. The audiologist who writes — or the practice marketing lead who can edit clinical drafts — has a sustainable AEO position.

Voice-first interfaces will compound the shift

Hearing-impaired demographics have always over-indexed on voice search by raw query volume, but the substrate is changing. The Pew Research Center older-adult tech adoption tracking shows 65+ smart-speaker households more than doubled between 2020 and 2024. Apple's iOS 18 Live Listen integration with Made for iPhone hearing aids has pulled audiology-related voice queries into Siri's conversational layer. Amazon's Alexa health-skill expansion (announced late 2025) explicitly targets hearing-care and pharmacy verticals.

When the voice interface is the front door, three things shift for hearing-care marketing:

1. Pronunciation matters. Brand names that voice models struggle to render (Phonak Lumity vs Oticon Intent) earn or lose recognition. Practices should publish phonetic guides where helpful.
2. Single-result answers. Voice gives one response, not ten blue links. The citation slot is winner-take-all per query intent. Second place is invisible.
3. Conversational refinement is the new keyword research. Users do not stop after one query. They refine. The practice that anticipates the refinement chain — "audiologist near me" → "one that takes Medicare Advantage" → "and fits Oticon" — has the next-question answer ready and gets cited at the conversion-adjacent turn.

For commerce-stage queries (the actual purchase decision), the AI assistant increasingly behaves like a shopping agent. We unpacked this dynamic for product pages in our Ecommerce AEO PDP guide. OTC hearing-aid pages need that treatment now; audiology practice pages need its provider-services equivalent.

What Sonova, GN, and the traditional majors are doing about it

The traditional hearing-aid majors are not standing still. Three strategic moves are underway as of mid-2026:

Sonova is investing aggressively in its independent-dispenser AEO support program — the company now provides member practices with schema templates, AI-citation tracking dashboards, and a content library that practices can syndicate (with canonical attribution back to Sonova). This is borrowed straight from the dental-implant and ophthalmology-major playbook of the past decade, but adapted for AI citation rather than backlink building.

GN Hearing is leveraging its Jabra audio brand to play both sides — premium Costco-fit channel and DTC OTC Enhance — while feeding the same product entity data into both channels. GN's product schema is among the most comprehensive in the category.

Demant (Oticon) and WS Audiology have moved more slowly on direct AEO but partnered with audiologist-network groups (Audigy, EarQ, Sonova's Audibel) to provide member-level support. The result is uneven; member practices that activate the programs are winning, those that do not still lag.

Starkey released a developer-facing API for hearing-aid telemetry data in late 2025 — a long bet on becoming the cited source for hearing-aid efficacy outcome data in academic and clinical research feeds, which trickles into LLM training corpora.

The takeaway is that the manufacturer layer recognized in 2025 that the practice-and-OTC-channel battleground was being recontested in AI search. The independent practice that does not align with a manufacturer's AEO support program (or build its own) is leaving leverage on the table.

Measuring what matters: the 2026 audiology AEO scorecard

Most audiology practice marketing dashboards still optimize for the metrics that mattered in 2018: Google Business Profile views, organic sessions, and form fills. Those still matter but no longer tell the visibility story. The Signal-recommended scorecard for an audiology practice in 2026:

The first three metrics are leading indicators. Booked consultations are the lagging indicator that converts every other metric to revenue. A practice with strong leading metrics and weak booking attribution likely has an intake-form problem, not a marketing problem — adding "How did you find us today? (ChatGPT / Perplexity / Google / Other AI / Referral / Other)" to the intake form costs nothing and unlocks the attribution conversation with the front desk.

What the next 18 months will look like

Two near-term shifts will reshape audiology AEO further:

The Apple AirPods hearing-aid feature — FDA-cleared in September 2024 and rolled out across compatible AirPods Pro 2 hardware — pulled an estimated 2-3 million additional users into self-managed hearing assistance during 2025. Many of those users will graduate from AirPods-based assistance to dedicated devices over the next 24 months. AI assistants increasingly treat AirPods as a category-comparison anchor. Audiology practices and OTC brands should publish content addressing the AirPods-to-dedicated-device upgrade path explicitly.

Medicare Advantage hearing-benefit consolidation — three major payers signaled in their 2026 plan year filings that they will narrow preferred-provider networks for hearing-aid benefits, citing cost-control. Audiology practices that secured preferred-provider status with major MA plans before this consolidation are pulling outsized AI citation share on insurance-specific queries. The window to claim those slots is closing through 2026 open-enrollment cycles.

The brands and practices that adapt to both shifts in the next 18 months will likely set the citation-share leaderboard for the rest of the decade. The ones that wait will spend 2027 trying to claw back share at multiples of the cost.

Takeaway: Audiology is in the middle of its second compounding disruption in five years. The FDA's OTC ruling opened the market; AI search is rewiring the discovery layer that now decides who wins inside it. The independent practice playbook is clear: claim every healthcare entity profile, publish service-and-insurance pages per office, deploy MedicalBusiness schema, build a review corpus rich in entity language, publish original outcome data quarterly, and earn one regional citation per quarter. The OTC challenger playbook is: dominate one comparison vector (price, discretion, telehealth, brand trust), structure your comparisons transparently, and feed product schema everywhere. The traditional majors will support whichever channel partners do the work. The patient at the center of all of this is on a smart speaker right now, asking a question, and the practice or brand that has done the AEO work will be the one named.